Loading...
17 Asia Oncology Reports
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: F. Hoffmann-La Roche Ltd, Johnson & Johnson, Endo Pharmaceutical Inc., AstraZeneca Plc, Bristol-Myers Squibb Company
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Bristol-Myers Squibb, Novartis AG, F. Hoffmann-La Roche AG, Pfizer Inc, Eli Lilly and Company
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Merck & Co., Inc, Eisai.Co.Ltd, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, AstraZeneca, Glaxosmithkline Plc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Pfizer Inc, F. Hoffmann-La Roche Ltd, Bayer AG, Novartis AG, Eisai.Co.Ltd
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Bayer AG, Siemens Healthineers GmbH
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Becton Dickinson and Company, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc.
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Astrazeneca plc, Glaxosmithkline Plc, Johnson and Johnson (Janssen Pharmaceuticals), F. Hoffmann-La Roche Ltd, Siemens Healthineers AG
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer AG, AstraZeneca PLC, Sanofi-Aventis, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Johnson & Johnson (Janssen Pharmaceutical), F. Hoffmann-La Roche, Merck & Co. Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Epigenomics AG, Abbott Laboratories, F. Hoffmann-La Roche AG, Novigenix SA, Amgen Inc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, United Kingdom, Germany, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Myriad Genetics, Inc., Pfizer, Inc, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bayer AG, F. Hoffmann-La Roche, Bristol Myers Squibb, Abbott Laboratories
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb, Novartis AG, F. Hoffmann-La Roche Ltd
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis AG, Becton, Dickinson and Company, Abbott Laboratories, F. Hoffman-La Roche Ltd, GlaxoSmithKline Plc
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Sanofi SA
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Teleflex, Novartis AG, Elekta, Siemens Healthcare GmbH, Bayer AG
Filter Reports
By Countries
